Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients

Clinical trial NCT00724776 · COMPLETED

Trial details

NCT number: NCT00724776
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2008-07-01
Primary completion: 2009-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.